Literature DB >> 32844239

Demographic and clinical profile of 1000 patients with thyroid eye disease presenting to a Tertiary Eye Care Institute in India.

Milind N Naik1, Varshitha Hemanth Vasanthapuram2.   

Abstract

PURPOSE: To assess the demographic and clinical profile of thyroid eye disease (TED) presenting to a Tertiary Eye Care Institute in India.
METHODS: All patients who were diagnosed to have TED between the year 2007 and 2017 at the Ophthalmic Plastic Surgery Service, LV Prasad Eye Institute, were included in this retrospective observational study. The demographic details of parameters such as age, gender and laterality, presenting signs and symptoms, clinical activity at presentation, and systemic thyroid status were assessed.
RESULTS: A total of 1000 consecutive patients of TED were evaluated in the 10-year period. Average age at presentation was 44.9 years (range 8-89). Of the 1000, 529 (53%) were males, and 358 (36%) had unilateral TED. At presentation, the TED was active (time since onset ≤ 12 months) in 476 (48%) cases and 71 (7%) had dysthyroid optic neuropathy. Of the 913 patients where systemic thyroid status was available at the time of presentation, 342 (37%) were euthyroid at presentation. Of the patients who were active at presentation (n = 476), 349 (70.3%) were 'Silent presenters' (Active as per timeline, but CAS ≤ 3). A prominent eye was the most common presenting symptom in 563 (64%) patients. Presenting signs in order of frequency were proptosis in 582 (58%), lower lid retraction (49%), upper lid retraction (48%), strabismus (6%), ptosis (5.5%), and corneal ulcer (1.3%).
CONCLUSIONS: TED in India presents to the tertiary eye center with slight male preponderance. One-third (37%) are euthyroid and half (48%) are active at presentation. One-third (35%) are silent presenters, with minimal clinical activity during the active phase of TED.

Entities:  

Keywords:  Epidemiology; Graves’ ophthalmopathy; Proptosis; Thyroid eye disease

Mesh:

Year:  2020        PMID: 32844239     DOI: 10.1007/s10792-020-01571-6

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  2 in total

1.  Prevalence of Graves' ophthalmopathy in patients with Graves' disease presenting to a referral centre in north India.

Authors:  Sagili Vijaya Bhaskar Reddy; Anu Jain; Subhash B Yadav; Kumudini Sharma; Eesh Bhatia
Journal:  Indian J Med Res       Date:  2014-01       Impact factor: 2.375

2.  Graves' orbitopathy: Management of difficult cases.

Authors:  Wilmar M Wiersinga
Journal:  Indian J Endocrinol Metab       Date:  2012-12
  2 in total
  4 in total

1.  Clinical characteristics and the treatment modalities of Graves' orbitopathy in a tertiary referral center in Turkey: changes over two decades.

Authors:  Mine Ozturk; Onur Konuk; Bercin Tarlan; Mehmet Muhittin Yalcın; Yavuz Kemal Arıbas; Fusun Balos Toruner; Mehmet Unal; Goksun Ayvaz
Journal:  Int Ophthalmol       Date:  2022-08-28       Impact factor: 2.029

Review 2.  Asymmetric Graves' Orbitopathy.

Authors:  Grigorios Panagiotou; Petros Perros
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-17       Impact factor: 5.555

3.  Topical Treatment of Elevated Intraocular Pressure in Patients with Graves' Orbitopathy.

Authors:  Magdalena Gumińska; Roman Goś; Janusz Śmigielski; Michał S Nowak
Journal:  Int J Environ Res Public Health       Date:  2020-12-13       Impact factor: 3.390

4.  Noninflammatory thyroid eye disease in Indian subcontinent: Is it a departure from Rundle's curve?

Authors:  Ayushi Agarwal; Samreen Khanam; Shalin Shah; Akash Raut
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.